A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma

BACKGROUND: Medulloblastoma is the most frequently occurring malignant brain tumor in children. Current treatment strategies for medulloblastoma include aggressive surgery, cranio-spinal irradiation and adjuvant chemotherapy. Because current treatments can cause severe long-term side effects and are...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shanshan, Gong, Zhaojian, Oladimeji, Peter O., Currier, Duane G., Deng, Qipan, Liu, Ming, Chen, Taosheng, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858705/
https://www.ncbi.nlm.nih.gov/pubmed/31788346
http://dx.doi.org/10.1186/s40164-019-0153-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858705/
https://www.ncbi.nlm.nih.gov/pubmed/31788346
http://dx.doi.org/10.1186/s40164-019-0153-x

Ejemplares similares